The National Pharmaceutical Pricing Authority (NPPA) on November 17, 2023, issued a notification regarding the fixation of the retail price of Benzyl Alcohol IP 1.1% v/v water for injections IP.
The following has been stated: -
•Each pack contains Vial-1 Lyophilized powder for concentrate for solution for intravenous infusion, multi-use vial Composition: Trastuzumab (r-DNA Origin) IH (Active Ingredient) 150 mg + α, α -Trehalose dihydrate USP (as Lyoprotectant) 136.2 mg + L-Histidine HCI Monohydrate EP (as buffering agent) 3.36 mg + L-Histidine USP (as buffering agent) 2.16mg + Polysorbate 20 IP (as Surfactant) 0.6 mg, Vial 2 bacteriostatic water for injection 10 ml single-use vial composition: Benzyl Alcohol IP 1.1% v/v water for injections IP for M/s Hetero Biopharma Ltd. (Manufacturer) and M/s Mankind Pharma Ltd (Marketer) and the Retail Price has been fixed at (Rs.) 15817.49.
The detailed notification is given in the document attached below.
[Notification No. 19(3573) /2023/DP/NPPA/Div.III/6968/2023]
